DalsnaFinance

Odyssey Therapeutics $ODTX

Health Care

Russell 2000 Massachusetts
Create a scorecard
$20.71
-0.02 (-0.10%)
As of Oct 5, 2026, 3:36 PM EDT
Price history
Loading chart…

Odyssey Therapeutics (ODTX) is trading down at $20.71 (-0.10%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: May 8, 2026 · $18.00 offering · NASDAQ · View IPO details →

Odyssey Therapeutics revenue & net income history

RevenueNet income
$1.92M−$25.4M−$52.8MQ1 FY2025 revenue: $1.92MQ1 FY2025 net income: −$38.4MQ1 '25Q2 FY2025 revenue: $959.0KQ2 FY2025 net income: −$41.2MQ2 '25Q1 FY2026 revenue: $0Q1 FY2026 net income: −$38.3MQ1 '26Q2 FY2026 revenue: $0Q2 FY2026 net income: −$52.8MQ2 '26
Odyssey Therapeutics quarterly financial statements
Q1 FY25Mar 2025Q2 FY25Jun 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Income statement
Revenue$1.92M$959.0K$0$0
Growth (year over year)——−100.0%−100.0%
Operating income−$39.2M−$41.9M−$39.8M−$55.5M
Operating margin−2041.7%−4371.3%——
Net income−$38.4M−$41.2M−$38.3M−$52.8M
Net margin−2003.9%−4299.8%——
EPS (diluted)−$39.37−$29.54−$6.77−$1.74
Balance sheet
Cash and equivalents$54.9M$163.0M$35.7M$82.0M
Total assets——$229.1M$483.9M
Total liabilities——$49.2M$62.6M
Shareholders' equity−$417.2M−$436.4M−$523.7M$421.2M
Cash flow
Operating cash flow−$38.6M−$34.3M−$41.0M−$34.5M
Capital expenditure$927.0K$29.0K$148.0K$186.0K
Free cash flow−$39.5M−$34.3M−$41.2M−$34.7M

From Odyssey Therapeutics's 10-Q filings with the SEC. Each period shows the latest figure the company has reported for it, including restatements. Filings on SEC EDGAR →

About Odyssey Therapeutics

Headquarters
Boston, Massachusetts From SEC filings, Oct 2026

Recent News (1)

More Health Care stocks

Browse all companies →